Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03734991 |
|---|---|
| Brief Title: | Efficacy and Safety of Oral Ibrexafungerp (SCY-078) vs. Placebo in Subjects With Acute Vulvovaginal Candidiasis (VANISH 303) |
| First Submitted : | October 30, 2018 |
| First Submitted that Met QC Criteria : | November 7, 2018 |
| First Posted : | November 8, 2018 |
| Results First Submitted : | June 30, 2021 |
| Results First Posted with QC Comments : | July 21, 2021 |
| Results First Submitted that Met QC Criteria : | August 11, 2021 |
| Results First Posted : | September 8, 2021 |
| Certification/Extension First Submitted : | September 1, 2020 |
| Certification/Extension First Submitted that Met QC Criteria : | August 11, 2021 |
| Certification/Extension First Posted : | September 8, 2021 |
| Last Update Submitted that Met QC Criteria : | August 11, 2021 |
| Last Update Posted : | September 8, 2021 |